Seguridad y eficacia de la vacuna BNT162B2 mRNA Covid-19
regresar
Seguridad y eficacia de la vacuna BNT162B2 mRNA Covid-19
Safety and Efficacy of the BNT162B2 mRNA Covid-19 Vaccine
12 de Diciembre del 2020
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and theresulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of peoplein a worldwide pandemic. Safe and effective vaccines are needed urgently.
DEJA UN COMENTARIO
Tu dirección de correo electrónico no sera publicada.